Using micromachines to control how cells behave and develop
Controlling Cellular Fate using Micromachines
['FUNDING_OTHER'] · UNIVERSITY OF DELAWARE · NIH-10912660
This study is exploring new ways to help cells talk and work together better, using tiny machines to guide their actions in real-time, which could lead to improved treatments for conditions like cancer and tissue damage.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF DELAWARE (nih funded) |
| Locations | 1 site (Newark, UNITED STATES) |
| Trial ID | NIH-10912660 on ClinicalTrials.gov |
What this research studies
This research focuses on improving how cells communicate and interact with each other to better control their development and function. By utilizing innovative micromachines, the project aims to create a system that can precisely direct cellular behavior in real-time, overcoming limitations of traditional methods that only provide static patterns. Patients may benefit from advancements in tissue engineering and regenerative medicine as this technology could lead to more effective therapies for various conditions, including cancers and tissue damage.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals with conditions that involve cellular dysfunction or require tissue regeneration.
Not a fit: Patients with stable, non-progressive conditions that do not involve cellular communication issues may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to breakthroughs in regenerative medicine and cancer treatment by enabling precise control over cell behavior.
How similar studies have performed: While the approach of using micromachines for cellular control is innovative, similar research has shown promise in related fields, indicating potential for success.
Where this research is happening
Newark, UNITED STATES
- UNIVERSITY OF DELAWARE — Newark, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: DAS, SAMBEETA — UNIVERSITY OF DELAWARE
- Study coordinator: DAS, SAMBEETA
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Cancers